NASDAQ:TVTX | EBITDA Margin | Travere Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-9.20%
2025-12-31-11.02%
2025-03-31-36.55%
2024-12-31-65.05%
2024-03-31-312.65%
2023-12-31-188.08%
2023-03-31-293.80%
2022-12-31-274.00%
2022-03-31-121.76%
2021-12-31241.30%
2021-03-31-87.49%
2020-12-31-219.52%
2020-03-31-19.70%
2019-12-31-49.00%
2019-03-31-84.22%
2018-12-31-0.24%
2018-03-31-35.29%
2017-12-31-25.39%
2017-03-31-30.11%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-0.42%
2024-12-31-120.20%
2023-12-31-240.71%
2022-12-31-273.25%
2021-12-31-141.60%
2020-12-31-76.43%
2019-12-31-66.70%
2018-12-31-37.37%
2017-12-31-23.23%
2016-12-31-31.50%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.